Diagnosis and phenotypic classification of Wilson disease 1
By P. Ferenci, K. Caca, G. Loudianos, G. Mieli‐Vergani, S. Tanner, I. Sternlieb, M. Schilsky, D. Cox, F. Berr. Liver international (Print), 2003
909 citations recorded by the source corpus.
Subfields: Health, Toxicology and Mutagenesis, Hematology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/7ea4eea26d664e08d3791ad3c9fe33e0584a6408
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Liyun Chen
- J. Min
- Fudi Wang
- R. Testa
- S. Lutsenko
- O. Dmitriev
- Natalie L Barnes
- E. Giannini
Citations in the corpus
- EASL Clinical Practice Guidelines: Wilson's disease. (2012, methodology): “Scoring system developed at the 8th International Meeting on Wilson’s disease, Leipzig 2001 [44].”
- Copper homeostasis and cuproptosis in health and disease (2022, background): “Patients with WD can present with liver symptoms that include fulminant hepatic failure (also known as acute liver failure), persistently elevated levels of serum aminotransferases, jaundice, and chronic hepatitis.(73) Interestingly, some patients do not manifest these hepatic changes, but instead p”
- Function and regulation of human copper-transporting ATPases. (2007, background): “Clinical aspects of Menkes disease and Wilson disease as well as currently available animal models have been described in recent literature (66, 90, 130, 131, 175, 250, 280, 281) and are not discussed here.”
- Liver enzyme alteration: a guide for clinicians (2005, background): “Finally, as many as 25% of the patients with AST levels greater than 10 times the upper reference limit may have acute extrahepatic biliary tract obstruction, which can be heralded by a peak in aminotransferase levels (> 50 times the upper reference value in 1%–2% of patients) that rapidly subsides ”